We reported that 12 serum markers of ECM metabolism, such as markers of collagen synthesis and controlling factors, including galectin-3, as well as the MMPs/TIMPs system, were of zero utility when it came to the prediction of EBM-assessed fibrosis in DCM [6,27]. The gene discussed is LGALS3; the disease is familial dilated cardiomyopathy.